109
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: A cross-sectional study

, , , &
Pages 1244-1248 | Received 06 Aug 2009, Accepted 20 Nov 2009, Published online: 04 Jan 2010

References

  • Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931–10934.
  • Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73–91.
  • Risau W. Mechanisms of angiogenesis. Nature 1997;86:671–674.
  • Kaufmann P, Bruns U, Leiser R, Luckhardt M, Winterhager E. The fetal vascularisation of term human placental villi. II.Intermediate and terminal villi. Anatomy and Embryology 1985;173:203–214.
  • Kaufmann P, Luckhardt M, Schweikhart G, Cantle SJ. Cross-sectional features and three dimensional structure of human placental villi. Placenta 1987;8:235–247.
  • Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenze GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor. Mol Cell Biol 1996;16:4604–4613.
  • Detmar M, Brown LF, Schön MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998;111:1–6.
  • Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468–471.
  • Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 2002;115:2559–2567.
  • Kendall RL, Wang G, and Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, Flt-1and its heterodimerization with KDR. Biochem Biophys Res Commun 1996;226:324–328.
  • Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005;26:210–217.
  • Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL, Peters A. Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab. 2006;290(3):434–439.
  • Malamitsi-Puchner A, Tziotis J, Tsonou A, Protonotariou E, Sarandakou A, Creatsas G. Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Investig 2000;7:309–312.
  • Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, et al Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435–439.
  • Malamitsi-Puchner A, Tziotis J, Protonotariou E, Sarandakou A, Creatsas G. Angiogenic factors in the perinatal period: diversity in biological functions reflected in their serum concentrations soon after birth. Ann N Y Acad Sci 2000;900:169–173.
  • Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007;112:51–57.
  • Gunga HC, Kirsch K, Rocker L, Behn C, Koralewski E, Davila LH, Estrada MI, Johannes B, Wittels P, Jelkmann W. Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol Occup Physiol 1999;79:484–490.
  • Ali KZM. Stereological study of the effect of altitude on the trophoblast cell populations of human placental villi. Placenta 1997;18:447–450.
  • Zamudio S, Baumann MU, Illsley NP. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. Placenta 2006;27:49–55.
  • Lawrence D. Longo. High altitude and pregnancy. LLU&MC Scope Autumn 1997. Available from: www.llu.edu/news/scope/aut97/alt.htm.
  • Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350(7):672–683.
  • Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke SW, Stillman IE, et al Excess placental soluble fms like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–658.
  • Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003;88:2348–2351.
  • Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005;122:33–39.
  • Wheeler T, Anthony FW, Young DA, Moore LG, Zamudio S. Maternal circulating vascular endothelial growth factor (VEGF) is elevated in high altitude pregnancy. J Soc Gynecol Investig 2002;9(Suppl):301A.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.